Produces and distributes a wide range of skin and body care products globally. Now — the numbers.
This is an established company with proven profits.
Average growth of 6% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $2.6B would still be left in the vault — a solid cushion for hard times.
The market pays 17.7× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
The stock trades 46% below its peak. The market has trimmed its expectations for the company.
There is $2.9B in the vault; even if every debt were paid off, $2.6B would remain.
It pays out $0.23 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back.
Against everything we grade, BDRFY lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BDRFY does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.